- African Energy 2024: Surging investment, waves of change
- AIM Congress 2025: Competition opens doors for Africa’s top tech innovators
- Zimbabwe rolls out $24M project to reduce use of mercury in gold mines
- Zambia secures $184M IMF support as economic growth set to decline to 1.2 per cent
- Equity enters alliance with ODDO BHF to spur Europe-Africa investments
- Air Tanzania hits turbulence: Can the airline fly back to EU skies?
- Ghana’s President Elect John Mahama Outlines His Economic Blueprint
- AfDB backs “green shares” funding model with $30M AFC equity boost
Browsing: mpox outbreak
- The bulk of the financing will go toward tackling mpox in 14 most affected African countries, and enhancing readiness efforts in 15 others.
- Other funds will go into operational and technical support, ensuring that the plan is executed through a network of partners.
- Africa CDC and WHO hope to reduce the virus’s impact and curb its spread.
The World Health Organisation (WHO) and the Africa Centres for Disease Control and Prevention (Africa CDC) have teamed up to counter the spread of Mpox across the continent in a new plan estimated at $600 million. This initiative, which is set to run between September 2024 and February next year, is poised to firm up Africa’s capacity to check the spread of the virus, cushion the populations at most risk and curb the spread of the disease.
Across the continent, mpox is spreading, and although calls for vaccines continue to intensify, the need …
- DRC announces receipt of the first shipment of 99,100 doses of JYNNEOS mpox vaccine.
- Africa CDC reports that another 100,900 mpox vaccine doses will arrive in DRC this Saturday.
- The country says the vaccination will prioritise health workers and vulnerable groups at higher risk of contracting mpox.
For millions of people in the Democratic Republic of Congo (DRC), the arrival of 99,100 doses of mpox vaccines presents hope and a lifeline as the disease threatens to damage the country’s socio-economic fabric. On Thursday, authorities in DRC announced the receipt of the first shipment of the JYNNEOS mpox vaccine.
This vital supply, facilitated by the Africa Centres for Disease Control and Prevention (Africa CDC) and UNICEF, marks the beginning of a nationwide vaccination campaign aimed at curbing the rapidly escalating mpox epidemic.
The first batch of vaccines was officially received by DRC’s Minister of Health, Samuel Roger Kamba, alongside high-ranking …
- WHO’s move aims to galvanize a coordinated international response to contain and mitigate the spread of mpox.
- An uptick in cases, especially in Burundi, Kenya, Uganda, and Rwanda, along with sporadic cases in Europe, prompted the WHO’s emergency declaration.
- Despite these concerns, mpox is not likely to evolve into a pandemic akin to COVID-19.
Last week, the World Health Organization (WHO) declared mpox (formerly known as monkeypox) a Public Health Emergency of International Concern. This decision underscores the escalating threat posed by the virus, which surged globally in 2022 but has since seen a troubling resurgence, particularly in Africa. The WHO’s move aims to galvanize a coordinated international response to contain and mitigate the spread of mpox, a virus with significant public health implications.
Mpox, a member of the same viral family as smallpox, is a rare but severe infection. It manifests through symptoms akin to chickenpox, including fevers, swollen …
- Health Minister Roger Kamba announced last week that the DRC expects to receive the first shipment of vaccine doses from the US within days.
- DRC is the hardest hit country by the epidemic globally reporting over 1000 new cases in a week.
- The country currently faces a huge shortfall in vaccine supplies, with an estimated 3 million doses required to curb the epidemic.
The US is expected to deliver critical Mpox vaccines to the Democratic Republic of Congo (DRC) this week, marking a turning point in Kinshasa’s fight against the fast-spreading viral infection. This intervention comes as the World Health Organization (WHO) declared Mpox outbreaks in Africa a global emergency, highlighting the urgent need for international support to combat the virus.
The DRC, which has been hardest hit by the epidemic reporting over 1000 new cases in a week, is poised to receive a much-needed boost in its battle against …
- DRC is grappling with a severe outbreak of Mpox, reporting over 1,000 new cases in just one week.
- This alarming surge has prompted health authorities in Africa to urgently request vaccines to combat the viral infection.
- Kenya, the DRC, Burundi, Rwanda, and Uganda are set to benefit from a donation of 50,000 doses of mpox vaccine as part of a global effort to check spread.
The Democratic Republic of Congo (DRC) is grappling with a severe Mpox outbreak, reporting over 1,000 new cases in just one week. This alarming surge has prompted health authorities in Africa to urgently request vaccines to combat what is increasingly seen as a growing threat on the continent. As the Mpox outbreak escalates, the need for international support has become more critical than ever.
The growing threat of Mpox in Africa
Mpox, a viral disease belonging to the same family as smallpox, is spreading rapidly …
- Africa CDC has announced an ambitious alliance with vaccine maker Bavarian Nordic to secure 10 million doses of the mpox vaccine by the end of 2025.
- Vaccine maker Bavarian Nordic says it can supply up to 2 million doses by the end of 2024.
- Mpox outbreak has been particularly severe, prompting Africa CDC to declare it a PHECS on August 13, 2024.
In response to the escalating threat of mpox across the Africa, the Africa Centers for Disease Control and Prevention (Africa CDC) has announced an ambitious plan to secure 10 million doses of the mpox vaccine by the end of 2025.
This commitment comes in collaboration with Bavarian Nordic, a leading vaccine manufacturer, which has pledged to ramp up production and ensure the equitable distribution of vaccines.
The initiative is a critical step in tackling the ongoing mpox outbreak, which has been declared a Public Health Emergency of …
- Suspected mpox cases across the continent have surged past 17,000—a sharp increase from 7,146 cases in 2022 and 14,957 cases in 2023.
- The disease has rapidly spread from the epicentre, DRC to at least 13 African countries, including nations previously unaffected such as Burundi, Kenya, Rwanda, and Uganda.
- Already, Africa CDC has entered into an alliance to provide over 215,000 doses of the MVA-BN® vaccine—the only Mpox vaccine approved by the FDA and EMA.
The Africa Centres for Disease Control and Prevention (Africa CDC) has declared the ongoing Mpox outbreak as a Public Health Emergency of Continental Security (PHECS).
This declaration is the first of its kind since the agency’s establishment in 2017, marking a critical moment in Africa’s public health scene even as authorities step up measures to tackle an outbreak of this deadly disease.
Under the authority granted by Article 3, Paragraph F of the Africa CDC Statutes, …